Closing Bell: Hls Therapeutics Inc down on Tuesday (HLS)

Today, Hls Therapeutics Inc stock opened at $3.45 and closed at $3.45. prices ranged from a low of $3.45 to a high of $3.46.

Shares decreased -0.58 percent from the previous day's close of $3.47.

During the day across North America, the TSX Composite closed 0.34% at 22751.68, the S&P 500 closed 0.28% at 5631.22, the Dow Jones Industrial Average closed 0.53% at 40211.72 and the Nasdaq Composite closed 0.40% at 18472.57.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 2,003 shares was traded during the session, with total trades of 9, while having an average volume of 3,381 over the last 5-days.

The TSX overall saw 4,226 price advancers against 1,023 declines and 82 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.25 (July 02,2024). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have shrunken -49.71%, while they have dipped -12.66% this year.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $110.40 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 5.00 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..